421 related articles for article (PubMed ID: 21359449)
1. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
2. [The expression of hTERT and p53 protein in pre-malignant and malignant lesions of human oral mucosa].
Wu GY; Zhu L; Feng ZQ; Peng T; Qi B
Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):51-4. PubMed ID: 15747015
[TBL] [Abstract][Full Text] [Related]
3. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
4. p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases.
Cuevas Gonzalez JC; Gaitan Cepeda LA; Borges Yanez SA; Cornejo AD; Mori Estevez AD; Huerta ER
Indian J Pathol Microbiol; 2016; 59(2):153-8. PubMed ID: 27166031
[TBL] [Abstract][Full Text] [Related]
5. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.
Angiero F; Berenzi A; Benetti A; Rossi E; Del Sordo R; Sidoni A; Stefani M; Dessy E
Anticancer Res; 2008; 28(5A):2535-9. PubMed ID: 19035275
[TBL] [Abstract][Full Text] [Related]
9. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
10. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
[TBL] [Abstract][Full Text] [Related]
11. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
12. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
16. In oral squamous cell carcinoma, high FAK expression is correlated with low P53 expression.
Rosado P; Lequerica-Fernández P; Peña I; Alonso-Durán L; de Vicente JC
Virchows Arch; 2012 Aug; 461(2):163-8. PubMed ID: 22790665
[TBL] [Abstract][Full Text] [Related]
17. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas.
Kudo Y; Takata T; Ogawa I; Sato S; Nikai H
Oncol Rep; 1999; 6(3):539-45. PubMed ID: 10203588
[TBL] [Abstract][Full Text] [Related]
20. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]